YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor

YY1 is a DNA-binding transcription factor and reported to be involved in cancer progression. Histone deacetylase inhibitor (HDACi) could inhibit proliferation and promote apoptosis of Hepatocellular carcinoma (HCC) cells. However, it is unclear about the roles of YY1 in the sensitivity of HCC cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Sheng, Ma, Xiang, Wang, Zusen, Han, Bing, Zou, Hao, Wu, Zehua, Zang, Yunjin, Zhuang, Likun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522268/
https://www.ncbi.nlm.nih.gov/pubmed/28489564
http://dx.doi.org/10.18632/oncotarget.17196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522268/
https://www.ncbi.nlm.nih.gov/pubmed/28489564
http://dx.doi.org/10.18632/oncotarget.17196

Ejemplares similares